-
proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and potent inhibitors of proteins has yielded remarkable results in disease
-
– Development of Lysine-Targeting, Cell-Active Covalent Inhibitors (CIs) with High Potency and Selectivity (MOE T2)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development
-
proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and potent inhibitors of proteins has yielded remarkable results in disease
Enter an email to receive alerts for Humanities "NATIONAL UNIVERSITY OF SINGAPORE" positions in CHEMISTRY